{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T19:05:32Z","timestamp":1786388732417,"version":"build-2736575974"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,11,17]],"date-time":"2022-11-17T00:00:00Z","timestamp":1668643200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,11,17]],"date-time":"2022-11-17T00:00:00Z","timestamp":1668643200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Diabetol"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Cardiovascular risk and body-weight management are both emerging challenges of type 1 diabetes care. We evaluated the association between intraindividual variability of body-weight and risk of cardiovascular events in people with type 1 diabetes.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We analyzed 1,398 participants from the DCCT\/EDIC studies. Five indices of intraindividual variability of body-weight were calculated for each participant taking into account body-weight measures obtained during the DCCT follow-up (average 6\u2009\u00b1\u20092\u00a0years). The Average Successive Variability (ASV) index, the main variable of interest, was defined as the average absolute difference between successive body-weight measures. The primary outcome was a composite of major adverse cardiovascular events (MACE: nonfatal myocardial infarction or stroke, or cardiovascular death) occurring during the subsequent EDIC follow-up (20\u2009\u00b1\u20093\u00a0years). All-cause death was a secondary outcome. Risk of outcomes were assessed by Cox proportional hazards regression analyses, adjusted for traditional cardiovascular risks factors, including BMI.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The cumulative incidence of MACE and all-cause death during follow-up were 5.6% (n\u2009=\u200979) and 6.8% (n\u2009=\u200995), respectively. The adjusted Hazard Ratio (HR) for MACE by every increase of 1 standard deviation (SD) of ASV was 1.34 (95% CI, 1.06\u20131.66), p\u2009=\u20090.01. For all-cause death, the adjusted HR for 1 SD increase of ASV was 1.25 (1.03\u20131.50), p\u2009=\u20090.03. Similar results were observed when considering the other indices of intraindividual variability of body-weight.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>High body-weight variability (body-weight cycling) is associated with increased risk of MACE and all-cause death in people with type 1 diabetes, independently of the BMI and traditional cardiovascular risk factors.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s12933-022-01689-0","type":"journal-article","created":{"date-parts":[[2022,11,17]],"date-time":"2022-11-17T12:03:54Z","timestamp":1668686634000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Body-weight variability and risk of cardiovascular outcomes in patients with type 1 diabetes: a retrospective observational analysis of data from the DCCT\/EDIC population"],"prefix":"10.1186","volume":"21","author":[{"given":"Iulia","family":"Petria","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel","family":"Albuquerque","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ga\u00ebl","family":"Varoquaux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jill-J\u00eann","family":"Vie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Venteclef","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamel","family":"Mohammedi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronan","family":"Roussel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marion","family":"Camoin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianluca","family":"Perseghin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gilberto","family":"Velho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louis","family":"Potier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,11,17]]},"reference":[{"key":"1689_CR1","doi-asserted-by":"publisher","first-page":"2252","DOI":"10.1016\/S0140-6736(12)60480-2","volume":"379","author":"AC Tricco","year":"2012","unstructured":"Tricco AC, Ivers NM, Grimshaw JM, Moher D, Turner L, Galipeau J, Halperin I, Vachon B, Ramsay T, Manns B, Tonelli M, Shojania K. Effectiveness of quality improvement strategies on the management of diabetes: a systematic review and meta-analysis. Lancet. 2012;379:2252\u201361.","journal-title":"Lancet"},{"key":"1689_CR2","doi-asserted-by":"publisher","first-page":"2579","DOI":"10.2337\/dc14-0096","volume":"37","author":"JL Harding","year":"2014","unstructured":"Harding JL, Shaw JE, Peeters A, Guiver T, Davidson S, Magliano DJ. Mortality trends among people with type 1 and type 2 diabetes in Australia: 1997\u20132010. Diabetes Care. 2014;37:2579\u201386.","journal-title":"Diabetes Care"},{"key":"1689_CR3","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1056\/NEJMoa1608664","volume":"376","author":"A Rawshani","year":"2017","unstructured":"Rawshani A, Rawshani A, Franzen S, Eliasson B, Svensson AM, Miftaraj M, McGuire DK, Sattar N, Rosengren A, Gudbjornsdottir S. Mortality and cardiovascular disease in type 1 and type 2 diabetes. N Engl J Med. 2017;376:1407\u201318.","journal-title":"N Engl J Med"},{"key":"1689_CR4","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1007\/s00125-022-05659-9","volume":"65","author":"PLD Ruiz","year":"2022","unstructured":"Ruiz PLD, Chen L, Morton JI, Salim A, Carstensen B, Gregg EW, Pavkov ME, Mata-Cases M, Mauricio D, Nichols GA, Pildava S, Read SH, Wild SH, Shaw JE, Magliano DJ. Mortality trends in type 1 diabetes: a multicountry analysis of six population-based cohorts. Diabetologia. 2022;65:964\u201372.","journal-title":"Diabetologia"},{"key":"1689_CR5","first-page":"1","volume-title":"Diabetes in America Cowie CC","author":"AM Secrest","year":"2018","unstructured":"Secrest AM, Washington RE, Orchard TJ. Mortality in type 1 diabetes. In: Casagrande SS, Menke A, Cissell MA, Eberhardt MS, Meigs JB, Gregg EW, Knowler WC, Barrett-Connor E, Becker DJ, Brancati FL, Boyko EJ, Herman WH, Howard BV, Narayan KMV, Rewers M, Fradkin JE, editors. Diabetes in America Cowie CC. Bethesda: National Institute of Diabetes and Digestive and Kidney Diseases (US); 2018. p. 1\u201316."},{"key":"1689_CR6","doi-asserted-by":"publisher","first-page":"1972","DOI":"10.1056\/NEJMoa1408214","volume":"371","author":"M Lind","year":"2014","unstructured":"Lind M, Svensson AM, Kosiborod M, Gudbjornsdottir S, Pivodic A, Wedel H, Dahlqvist S, Clements M, Rosengren A. Glycemic control and excess mortality in type 1 diabetes. N Engl J Med. 2014;371:1972\u201382.","journal-title":"N Engl J Med"},{"key":"1689_CR7","doi-asserted-by":"publisher","first-page":"1885","DOI":"10.2337\/dc20-2816","volume":"44","author":"V Harjutsalo","year":"2021","unstructured":"Harjutsalo V, Barlovic DP, Gordin D, Forsblom C, King G, Groop PH. FinnDiane Study Group: presence and determinants of cardiovascular disease and mortality in individuals with type 1 diabetes of long duration: the Finndiane 50 years of diabetes study. Diabetes Care. 2021;44:1885\u201393.","journal-title":"Diabetes Care"},{"key":"1689_CR8","doi-asserted-by":"publisher","first-page":"3216","DOI":"10.2337\/db10-0862","volume":"59","author":"AM Secrest","year":"2010","unstructured":"Secrest AM, Becker DJ, Kelsey SF, Laporte RE, Orchard TJ. Cause-specific mortality trends in a large population-based cohort with long-standing childhood-onset type 1 diabetes. Diabetes. 2010;59:3216\u201322.","journal-title":"Diabetes"},{"key":"1689_CR9","doi-asserted-by":"publisher","first-page":"2843","DOI":"10.2337\/dc14-1720","volume":"37","author":"SD de Ferranti","year":"2014","unstructured":"de Ferranti SD, de Boer IH, Fonseca V, Fox CS, Golden SH, Lavie CJ, Magge SN, Marx N, McGuire DK, Orchard TJ, Zinman B, Eckel RH. Type 1 diabetes mellitus and cardiovascular disease: a scientific statement from the American Heart Association and American Diabetes Association. Diabetes Care. 2014;37:2843\u201363.","journal-title":"Diabetes Care"},{"key":"1689_CR10","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1056\/NEJM199309303291401","volume":"329","author":"DM Nathan","year":"1993","unstructured":"Nathan DM, Genuth S, Lachin J, Cleary P, Crofford O, Davis M, Rand L, Siebert C, The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993;329:977\u201386.","journal-title":"N Engl J Med"},{"key":"1689_CR11","doi-asserted-by":"publisher","first-page":"686","DOI":"10.2337\/dc15-1990","volume":"39","author":"Diabetes Control and Complications Trial (DCCT) \/ Epidemiology of Diabetes Interventions and Complications (EDIC) Study Research Group","year":"2016","unstructured":"Diabetes Control and Complications Trial (DCCT) \/ Epidemiology of Diabetes Interventions and Complications (EDIC) Study Research Group. Intensive diabetes treatment and cardiovascular outcomes in type 1 diabetes: the DCCT\/EDIC study 30-year follow-up. Diabetes Care. 2016;39:686\u201393.","journal-title":"Diabetes Care"},{"key":"1689_CR12","doi-asserted-by":"publisher","first-page":"3976","DOI":"10.2337\/db13-1093","volume":"62","author":"DM Nathan","year":"2013","unstructured":"Nathan DM, Bayless M, Cleary P, Genuth S, Gubitosi-Klug R, Lachin JM, Lorenzi G, Zinman B. The DCCT \/ EDIC Research Group: Diabetes control and complications trial\/epidemiology of diabetes interventions and complications study at 30 years: advances and contributions. Diabetes. 2013;62:3976\u201386.","journal-title":"Diabetes"},{"key":"1689_CR13","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1161\/CIRCULATIONAHA.111.077487","volume":"127","author":"JQ Purnell","year":"2013","unstructured":"Purnell JQ, Zinman B, Brunzell JD. DCCT \/ EDIC Research Group: the effect of excess weight gain with intensive diabetes mellitus treatment on cardiovascular disease risk factors and atherosclerosis in type 1 diabetes mellitus: results from the Diabetes Control and Complications Trial\/Epidemiology of Diabetes Interventions and Complications Study (DCCT\/EDIC) study. Circulation. 2013;127:180\u20137.","journal-title":"Circulation"},{"key":"1689_CR14","doi-asserted-by":"publisher","first-page":"1756","DOI":"10.2337\/dc16-2523","volume":"40","author":"JQ Purnell","year":"2017","unstructured":"Purnell JQ, Braffett BH, Zinman B, Gubitosi-Klug RA, Sivitz W, Bantle JP, Ziegler G, Cleary PA, Brunzell JD. DCCT\/EDIC Research Group: impact of excessive weight gain on cardiovascular outcomes in type 1 diabetes: results from the diabetes control and complications trial\/epidemiology of diabetes interventions and complications (DCCT\/EDIC) study. Diabetes Care. 2017;40:1756\u201362.","journal-title":"Diabetes Care"},{"key":"1689_CR15","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1001\/archinte.1994.00420120035004","volume":"154","author":"KD Brownell","year":"1994","unstructured":"Brownell KD, Rodin J. Medical, metabolic, and psychological effects of weight cycling. Arch Intern Med. 1994;154:1325\u201330.","journal-title":"Arch Intern Med"},{"key":"1689_CR16","doi-asserted-by":"publisher","first-page":"1839","DOI":"10.1056\/NEJM199106273242602","volume":"324","author":"L Lissner","year":"1991","unstructured":"Lissner L, Odell PM, D\u2019Agostino RB, Stokes J 3rd, Kreger BE, Belanger AJ, Brownell KD. Variability of body weight and health outcomes in the Framingham population. N Engl J Med. 1991;324:1839\u201344.","journal-title":"N Engl J Med"},{"key":"1689_CR17","doi-asserted-by":"publisher","first-page":"2627","DOI":"10.1161\/CIRCULATIONAHA.118.034978","volume":"138","author":"MK Kim","year":"2018","unstructured":"Kim MK, Han K, Park YM, Kwon HS, Kang G, Yoon KH, Lee SH. Associations of variability in blood pressure, glucose and cholesterol concentrations, and body mass index with mortality and cardiovascular outcomes in the general population. Circulation. 2018;138:2627\u201337.","journal-title":"Circulation"},{"key":"1689_CR18","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1056\/NEJMoa1606148","volume":"376","author":"S Bangalore","year":"2017","unstructured":"Bangalore S, Fayyad R, Laskey R, DeMicco DA, Messerli FH, Waters DD. Body-weight fluctuations and outcomes in coronary disease. N Engl J Med. 2017;376:1332\u201340.","journal-title":"N Engl J Med"},{"key":"1689_CR19","doi-asserted-by":"publisher","first-page":"2234","DOI":"10.2337\/dc19-2552","volume":"43","author":"GE Nam","year":"2020","unstructured":"Nam GE, Kim W, Han K, Lee CW, Kwon Y, Han B, Park S, Park JH, Kim YH, Kim DH, Kim SM, Choi YS, Cho KH, Park YG. Body weight variability and the risk of cardiovascular outcomes and mortality in patients with type 2 diabetes: a nationwide cohort study. Diabetes Care. 2020;43:2234\u201341.","journal-title":"Diabetes Care"},{"key":"1689_CR20","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1186\/s12933-021-01360-0","volume":"20","author":"A Ceriello","year":"2021","unstructured":"Ceriello A, Lucisano G, Prattichizzo F, Eliasson B, Franzen S, Svensson AM, Nicolucci A. Variability in body weight and the risk of cardiovascular complications in type 2 diabetes: results from the Swedish National Diabetes Register. Cardiovasc Diabetol. 2021;20:173.","journal-title":"Cardiovasc Diabetol"},{"key":"1689_CR21","doi-asserted-by":"publisher","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","volume":"150","author":"AS Levey","year":"2009","unstructured":"Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF, Feldman HI, Kusek JW, Eggers P, Van Lente F, Greene T, Coresh J. CKD-EPI group: a new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150:604\u201312.","journal-title":"Ann Intern Med"},{"key":"1689_CR22","doi-asserted-by":"publisher","first-page":"567","DOI":"10.2337\/diacare.11.7.567","volume":"11","author":"The Diabetes Control and Complications Trial Research Group","year":"1988","unstructured":"The Diabetes Control and Complications Trial Research Group. Weight gain associated with intensive therapy in the diabetes control and complications trial. The DCCT Research Group. Diabetes Care. 1988;11:567\u201373.","journal-title":"Diabetes Care"},{"key":"1689_CR23","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.2337\/db15-1517","volume":"65","author":"Diabetes Control and Complications Trial (DCCT) \/ Epidemiology of Diabetes Interventions and Complications (EDIC) Study Research Group","year":"2016","unstructured":"Diabetes Control and Complications Trial (DCCT) \/ Epidemiology of Diabetes Interventions and Complications (EDIC) Study Research Group. Risk factors for cardiovascular disease in type 1 diabetes. Diabetes. 2016;65:1370\u20139.","journal-title":"Diabetes"},{"key":"1689_CR24","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.21105\/joss.01317","volume":"4","author":"C Davidson-Pilon","year":"2019","unstructured":"Davidson-Pilon C. Lifelines: survival analysis in Python. JOSS. 2019;4:1317.","journal-title":"JOSS"},{"key":"1689_CR25","doi-asserted-by":"publisher","DOI":"10.1111\/dme.14794","volume":"39","author":"NE Carlson","year":"2022","unstructured":"Carlson NE, Horton KW, Hokanson JE, Cleary PA, Jacobs DR Jr, Brunzell JD, Purnell JQ. DCCT EDIC research group: weight gain trajectories and obesity rates in intensive and conventional treatments of type 1 diabetes from the DCCT compared with a control population without diabetes. Diabet Med. 2022;39: e14794.","journal-title":"Diabet Med"},{"key":"1689_CR26","doi-asserted-by":"publisher","first-page":"2643","DOI":"10.1056\/NEJMoa052187","volume":"353","author":"DM Nathan","year":"2005","unstructured":"Nathan DM, Cleary PA, Backlund JY, Genuth SM, Lachin JM, Orchard TJ, Raskin P, Zinman B. DCCT\/EDIC Group: Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N Engl J Med. 2005;353:2643\u201353.","journal-title":"N Engl J Med"},{"key":"1689_CR27","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1016\/S2213-8587(21)00246-1","volume":"9","author":"B Van der Schueren","year":"2021","unstructured":"Van der Schueren B, Ellis D, Faradji RN, Al-Ozairi E, Rosen J, Mathieu C. Obesity in people living with type 1 diabetes. Lancet Diabetes Endocrinol. 2021;9:776\u201385.","journal-title":"Lancet Diabetes Endocrinol"},{"key":"1689_CR28","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1111\/dom.13197","volume":"20","author":"A Bumbu","year":"2018","unstructured":"Bumbu A, Moutairou A, Matar O, Fumeron F, Velho G, Riveline JP, Gautier JF, Marre M, Roussel R, Potier L. Non-severe hypoglycaemia is associated with weight gain in patients with type 1 diabetes: Results from the Diabetes Control and Complication Trial. Diabetes Obes Metab. 2018;20:1289\u201392.","journal-title":"Diabetes Obes Metab"},{"key":"1689_CR29","doi-asserted-by":"crossref","first-page":"191","DOI":"10.70252\/ASAQ8961","volume":"2","author":"K Strohacker","year":"2009","unstructured":"Strohacker K, Carpenter KC, McFarlin BK. Consequences of weight cycling: an increase in disease risk? Int J Exerc Sci. 2009;2:191\u2013201.","journal-title":"Int J Exerc Sci"},{"key":"1689_CR30","first-page":"98","volume":"2","author":"K Strohacker","year":"2010","unstructured":"Strohacker K, McFarlin BK. Influence of obesity, physical inactivity, and weight cycling on chronic inflammation. Front Biosci. 2010;2:98\u2013104.","journal-title":"Front Biosci"},{"key":"1689_CR31","first-page":"2052","volume":"16","author":"X Li","year":"2018","unstructured":"Li X, Jiang L, Yang M, Wu YW, Sun JZ. Impact of weight cycling on CTRP3 expression, adipose tissue inflammation and insulin sensitivity in C57BL\/6J mice. Exp Ther Med. 2018;16:2052\u20139.","journal-title":"Exp Ther Med"},{"key":"1689_CR32","doi-asserted-by":"publisher","first-page":"1368","DOI":"10.1016\/j.mayocp.2014.04.033","volume":"89","author":"QR Pack","year":"2014","unstructured":"Pack QR, Rodriguez-Escudero JP, Thomas RJ, Ades PA, West CP, Somers VK, Lopez-Jimenez F. The prognostic importance of weight loss in coronary artery disease: a systematic review and meta-analysis. Mayo Clin Proc. 2014;89:1368\u201377.","journal-title":"Mayo Clin Proc"}],"container-title":["Cardiovascular Diabetology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-022-01689-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12933-022-01689-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-022-01689-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,8]],"date-time":"2024-10-08T23:43:11Z","timestamp":1728430991000},"score":1,"resource":{"primary":{"URL":"https:\/\/cardiab.biomedcentral.com\/articles\/10.1186\/s12933-022-01689-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,17]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["1689"],"URL":"https:\/\/doi.org\/10.1186\/s12933-022-01689-0","relation":{},"ISSN":["1475-2840"],"issn-type":[{"value":"1475-2840","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,17]]},"assertion":[{"value":"18 August 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 October 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 November 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The institutional review board (IRB0006477) of Bichat Hospital, Assistance Public-H\u00f4pitaux de Paris (APHP), Paris, France gave a waiver of approval for this retrospective analysis of the publicly available DCCT and EDIC data sets.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"KM reports personal fees or non-financial support from Novo Nordisk, Sanofi, Astra-Zeneca, Eli Lilly, Abbott, and Boehringer-Ingelheim. RR reports research grants from Sanofi, Novo Nordisk, and Diabnext, consulting and speakers\u2019 bureau fees (compensation donated to the nonprofit Foundation APHP for Research) from Sanofi, Novo Nordisk, Eli Lilly, Boehringer-Ingelheim, Mundipharma, Janssen, AstraZeneca, MSD, Medtronic, and Abbott. GP reports consulting and speakers\u2019 bureau fees from Sanofi, Novo Nordisk, Eli Lilly, Boehringer-Ingelheim, Mundipharma, AstraZeneca, MSD, Pfizer, Novartis, PikDare, Intercept, Servier, Daiichi Sankyo, Bayer. LP reports grants, personal fees and non-financial support from Bayer, Novo Nordisk, Sanofi, Eli Lilly, Boehringer Ingelheim and Astra-Zeneca. All other authors declare that there is no duality of interest associated with their contribution to the manuscript.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"247"}}